Literature DB >> 30069243

Advanced Atherosclerosis with Leriche Syndrome, in a Patient with Carney Complex.

Ionela-Simona Visoiu1, Cristina Constantinescu1, Natalia Patrascu1, Claudiu Ionut Stoicescu1, Bogdan Dorobat2, Radu Brezeanu1, Cristina Anton1, Dragos Vinereanu1, Mircea Cinteza1.   

Abstract

Carney complex (CNC) is a rare autosomal dominant syndrome. Spotty skin pigmentation is the major clinical manifestation of CNC, followed by cardiac myxomas, benign tumors that usually present with features from the classical triad of obstructive cardiac, embolic and non-specific constitutional symptoms (NCS). NCS are caused by the overproduction of interleukin-6 (IL-6), a pro-inflammatory cytokine which mediates the induction of intercellular adhesion molecule 1 (ICAM-1) and promotes endothelial dysfunction and atherosclerosis. Thus, myxomas may be directly linked to an increased risk of atherosclerotic events. We report here a case of a 74-year-old woman with left atrial myxoma, skin pigmentary abnormalities, thyroid disorder and extensive atherosclerosis, with non-embolic occlusion of infrarenal abdominal aorta.

Entities:  

Year:  2018        PMID: 30069243      PMCID: PMC6060295          DOI: 10.26574/maedica.2018.13.2.147

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  13 in total

1.  Asymptomatic giant left atrial myxoma supplied from right coronary artery in a 65-year-old woman.

Authors:  Mehmet Yazici; Tugrul Norgaz; Ramazan Akdemir; Sinan Albayrak
Journal:  Int J Cardiol       Date:  2005-06-08       Impact factor: 4.164

Review 2.  Carney complex: an update.

Authors:  Ricardo Correa; Paraskevi Salpea; Constantine A Stratakis
Journal:  Eur J Endocrinol       Date:  2015-06-30       Impact factor: 6.664

Review 3.  Cardiac myxoma: imaging features in 83 patients.

Authors:  Mary L Grebenc; Melissa L Rosado-de-Christenson; Curtis E Green; Allen P Burke; Jeffrey R Galvin
Journal:  Radiographics       Date:  2002 May-Jun       Impact factor: 5.333

4.  Atrial myxoma: a rare but well-described cause of increased erythrocyte sedimentation rate and anaemia.

Authors:  Mattias Ekström; Peter Svenarud
Journal:  BMJ Case Rep       Date:  2015-05-12

5.  The role of interleukin-6 in cases of cardiac myxoma. Clinical features, immunologic abnormalities, and a possible role in recurrence.

Authors:  C E Mendoza; M F Rosado; L Bernal
Journal:  Tex Heart Inst J       Date:  2001

6.  Left atrial myxoma associated with obstructive coronary artery disease.

Authors:  Ronaldo Altenburg Odebrecht Curi Gismondi; Renato Kaufman; Gabriel Angelo de Cata Preta Correa; César Nascimento; Luiz Henrique Weitzel; José Oscar Brito Reis; Antônio Sérgio Cordeiro da Rocha; Ademir Batista da Cunha
Journal:  Arq Bras Cardiol       Date:  2007-01       Impact factor: 2.000

7.  The role of tumor vascularisation in benign and malignant cardiovascular neoplasms: a comparison of cardiac myxoma and sarcomas of the pulmonary artery.

Authors:  Andreas Gaumann; Gerson Strubel; Beata Bode-Lesniewska; Irene Schmidtmann; Jörg Kriegsmann; C James Kirkpatrick
Journal:  Oncol Rep       Date:  2008-08       Impact factor: 3.906

8.  The complex of myxomas, spotty skin pigmentation and endocrine overactivity (Carney complex): imaging findings with clinical and pathological correlation.

Authors:  Nikos A Courcoutsakis; Christina Tatsi; Nicholas J Patronas; Chiy-Chia Richard Lee; Panos K Prassopoulos; Constantine A Stratakis
Journal:  Insights Imaging       Date:  2013-01-12

9.  Atypical vessels as an early sign of intracardiac myxoma?

Authors:  Hans-Peter Dübel; Fabian Knebel; Volker Gliech; Wolfgang Konertz; Wolfgang Rutsch; Gert Baumann; Adrian Constantin Borges
Journal:  Cardiovasc Ultrasound       Date:  2004-08-13       Impact factor: 2.062

10.  Biatrial myxoma and multiple organ infarctions combined with Leriche syndrome in a female patient.

Authors:  Seung Yeon Min; Young-Hyo Lim; Hyung Tak Lee; Jinho Shin; Kyung-Soo Kim; Hyuck Kim
Journal:  BMC Cardiovasc Disord       Date:  2014-12-05       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.